Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
New York State Jury Finds Manufacturer Teva and Distributor Anda Liable for Fueling Opioid Epidemic in New York State - Simmons Hanly Conroy
Zydus Healthcare buys 2 ANDAs from Teva - The Economic Times
Allergan sells Anda to Teva for $500 million - CDR – Chain Drug Review
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva completes $40.5B Actavis deal, agrees to buy Anda for $500M - Philadelphia Business Journal
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva buys Anda for $500 million - ISRAEL21c
Dr Reddy's completes acquisition of 8 Teva ANDAs - The Hindu BusinessLine
Anda - Crunchbase Company Profile & Funding
Teva Takes Aim At First Truvada And Atripla Generics In US :: Generics Bulletin
Teva's Generic Value Chain Differentiates It from Its Peers
Teva Pharmaceuticals USA and Anda, Inc.... - Kids In Distress | Facebook
Teva to Buy Generics Distributor Anda From Allergan for $500 Million - WSJ
Generics distributor Anda, Inc. has a new owner: Teva Pharma
New York Opioid Trial: Allergan Settlement Leaves Teva as Last Target - Bloomberg
Evoke Announces Teva Ends Pursuit of Paragraph IV ANDA
Teva Holds off Huntington's Competitor, Resolves Opioid Cases | BioSpace
Teva issues in line guidance as North American revenue remains flat
Who We Are | AndaNet
Sex, drugs, and sharing trade secrets
Teva Completes Acquisition of Anda Inc | World Pharma Today
